Related references
Note: Only part of the references are listed.Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin
Devita Surjana et al.
CARCINOGENESIS (2013)
Nicotinamide riboside, a trace nutrient in foods, is a Vitamin B3 with effects on energy metabolism and neuroprotection
Yuling Chi et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)
Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession (vol 34, pg 1564, 2013)
D. Liu et al.
NEUROBIOLOGY OF AGING (2013)
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models
Bing Gong et al.
NEUROBIOLOGY OF AGING (2013)
The effect of nicotinamide on gene expression in a traumatic brain injury model
G. D. Anderson et al.
FRONTIERS IN NEUROSCIENCE (2013)
Neuroprotection for ischaemic stroke: Translation from the bench to the bedside
Brad A. Sutherland et al.
INTERNATIONAL JOURNAL OF STROKE (2012)
Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials
Devita Surjana et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A Comparison of the Effects of Nicotinamide and Progesterone on Functional Recovery of Cognitive Behavior following Cortical Contusion Injury in the Rat
Todd C. Peterson et al.
JOURNAL OF NEUROTRAUMA (2012)
Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury
Cole Vonder Haar et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Mitochondrial Dysfunction and Nicotinamide Dinucleotide Catabolism as Mechanisms of Cell Death and Promising Targets for Neuroprotection
Tibor Kristian et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Preclinical Efficacy Testing in Middle-Aged Rats: Nicotinamide, a Novel Neuroprotectant, Demonstrates Diminished Preclinical Efficacy after Controlled Cortical Impact
Alicia A. Swan et al.
JOURNAL OF NEUROTRAUMA (2011)
Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging
Yakup Batlevi et al.
NEUROBIOLOGY OF DISEASE (2011)
Treatment of Parkinson's disease with NADH
N. Dizdar et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer
Mara Galli et al.
CANCER RESEARCH (2010)
Vitamin B3, the nicotinamide adenine dinucleotides and aging
Ping Xu et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury
Andrea M. Goffus et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Nicotinamide Prevents Ultraviolet Radiation-induced Cellular Energy Loss
Joohong Park et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2010)
Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus
Jufang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
Rupinder K. Sodhi et al.
VASCULAR PHARMACOLOGY (2010)
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats
Paola Morales et al.
EXPERIMENTAL BRAIN RESEARCH (2010)
Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans
G. Sivapirabu et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian Degeneration
Naoki Yahata et al.
JOURNAL OF NEUROSCIENCE (2009)
Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
Dong Liu et al.
NEUROMOLECULAR MEDICINE (2009)
Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau
Kim N. Green et al.
JOURNAL OF NEUROSCIENCE (2008)
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress
Craig Press et al.
JOURNAL OF NEUROSCIENCE (2008)
High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease
Haiqun Jia et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury
Michael A. Holland et al.
JOURNAL OF NEUROTRAUMA (2008)
NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration
R. Grace Zhai et al.
NATURE (2008)
Promotion of cellular NAD+ anabolism:: Therapeutic potential for oxidative stress in ageing and Alzheimer's disease
Nady Braidy et al.
NEUROTOXICITY RESEARCH (2008)
NAD+ and vitamin B3:: From metabolism to therapies
Anthony A. Sauve
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Sirtuins as potential targets for metabolic syndrome
Leonard Guarente
NATURE (2006)
Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity
R. Grace Zhai et al.
PLOS BIOLOGY (2006)
Plasticity of the central nervous system (CNS) following perinatal asphyxia: Does nicotinamide provide neuroprotection?
V. Klawitter et al.
AMINO ACIDS (2006)
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
Yo Sasaki et al.
JOURNAL OF NEUROSCIENCE (2006)
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction
Weiping Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Taichi Hara et al.
NATURE (2006)
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Masaaki Komatsu et al.
NATURE (2006)
Messenger-specific role for nicotinic acid adenine dinucleotide phosphate in neuronal differentiation
Eugen Brailoiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory
A Fischer et al.
NEURON (2005)
Metabolic and endocrinological causes of dementia
L Flicker et al.
INTERNATIONAL PSYCHOGERIATRICS (2005)
Treatment with reduced nicotinamide adenine dinucleotide (NADH) improves water maze performance in old Wistar rats
A Rex et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
T Araki et al.
SCIENCE (2004)
Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline
MC Morris et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Pellagra: Dermatitis, dementia, and diarrhea
J Hegyi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
Early administration of nicotinamide prevents learning and memory impairment in mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J Yang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Nicotinamide attenuates focal ischemic brain injury in rats:: With special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra
F Sadanaga-Akiyoshi et al.
NEUROCHEMICAL RESEARCH (2003)
Autoimmune bullous dermatoses in the elderly - Diagnosis and management
DF Mutasim
DRUGS & AGING (2003)
Role of mitochondrial dysfunction in Alzheimer's disease
R Castellani et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Pellagra and skin
K Karthikeyan et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Bioavailability of reduced nicotinamide-adenin-dinucleotide (NADH) in the central nervous system of the anaesthetized rat measured by laser-induced fluorescence spectroscopy
A Rex et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia?
JP Blass
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
TGA Mack et al.
NATURE NEUROSCIENCE (2001)
Safety of high dose nicotinamide: a review
M Knip et al.
DIABETOLOGIA (2000)
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia
M Rainer et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
